tiprankstipranks
Trending News
More News >
Noumi Limited (AU:NOU)
:NOU
Australian Market
Advertisement

Noumi Limited (NOU) AI Stock Analysis

Compare
4 Followers

Top Page

AU:NOU

Noumi Limited

(Sydney:NOU)

Select Model
Select Model
Select Model
Underperform 40 (OpenAI - 4o)
Rating:40Underperform
Price Target:
AU$0.00
▼(-100.00% Downside)
Noumi Limited's overall stock score reflects significant financial challenges, including negative profitability and high leverage. Technical indicators suggest bearish momentum, while valuation metrics highlight ongoing financial difficulties. The lack of earnings call and corporate events data limits further insights.

Noumi Limited (NOU) vs. iShares MSCI Australia ETF (EWA)

Noumi Limited Business Overview & Revenue Model

Company DescriptionNoumi Limited (NOU) is a diversified company focused on health and wellness solutions, operating primarily in the nutraceuticals and functional foods sectors. The company offers a range of products designed to promote physical and mental well-being, including dietary supplements, plant-based proteins, and wellness beverages. Noumi Limited is committed to innovation and sustainability, providing high-quality products that cater to the growing demand for natural health solutions.
How the Company Makes MoneyNoumi Limited generates revenue through the sale of its core products, which include dietary supplements and functional foods. The company's revenue model primarily relies on direct sales to consumers via e-commerce platforms and retail partnerships. Key revenue streams include product sales, subscriptions for regular deliveries of health products, and collaborations with health professionals and fitness centers. Significant partnerships with retailers and online marketplaces enhance its distribution capabilities, driving customer acquisition and increasing sales volume. Additionally, Noumi Limited's focus on brand loyalty and customer retention through high-quality products and customer engagement strategies contributes to its earnings.

Noumi Limited Financial Statement Overview

Summary
Noumi Limited faces significant financial challenges, with a negative net profit margin and declining EBITDA margin. The balance sheet shows high leverage and negative equity, indicating financial instability. While there are some improvements in cash flow, overall financial health remains concerning.
Income Statement
45
Neutral
Noumi Limited has shown some improvement in its gross profit margin over the years, reaching 27.14% in 2025, indicating better cost management. However, the company continues to face challenges with profitability, as evidenced by a negative net profit margin of -25.18% and a declining EBITDA margin. Revenue growth has been inconsistent, with a notable increase in 2025, but past fluctuations suggest volatility in sales performance.
Balance Sheet
30
Negative
The balance sheet reveals significant financial instability, with a negative stockholders' equity indicating potential solvency issues. The debt-to-equity ratio is negative, reflecting high leverage and financial risk. Although there is a slight improvement in return on equity, the overall financial health remains concerning due to persistent negative equity.
Cash Flow
40
Negative
Cash flow analysis shows some positive trends, such as a reduction in negative free cash flow and an improvement in operating cash flow. However, the operating cash flow to net income ratio remains low, indicating challenges in converting income into cash. The free cash flow to net income ratio is relatively high, suggesting some efficiency in cash management despite overall financial struggles.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue595.84M595.84M589.79M551.56M522.34M547.29M
Gross Profit161.72M161.72M145.75M134.77M98.42M93.53M
EBITDA-50.33M-138.96M-61.24M-6.37M-122.53M28.01M
Net Income-150.00M-150.00M-98.33M-46.91M-160.74M-53.18M
Balance Sheet
Total Assets265.17M265.17M316.20M377.95M420.13M538.67M
Cash, Cash Equivalents and Short-Term Investments23.18M23.18M21.57M18.56M16.21M31.67M
Total Debt614.75M614.75M533.76M491.00M455.01M462.39M
Total Liabilities717.51M717.51M621.14M581.49M569.14M537.18M
Stockholders Equity-452.34M-452.34M-304.94M-203.54M-149.01M1.49M
Cash Flow
Free Cash Flow27.66M27.66M11.02M-49.00K-46.87M-56.67M
Operating Cash Flow32.52M32.52M15.83M4.31M-40.86M-54.01M
Investing Cash Flow2.09M2.09M1.84M2.22M-3.93M13.50M
Financing Cash Flow-33.01M-33.01M-21.64M-4.18M29.33M53.80M

Noumi Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price0.14
Price Trends
50DMA
0.15
Negative
100DMA
0.14
Positive
200DMA
0.15
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
51.31
Neutral
STOCH
33.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOU, the sentiment is Neutral. The current price of 0.14 is above the 20-day moving average (MA) of 0.14, below the 50-day MA of 0.15, and below the 200-day MA of 0.15, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 51.31 is Neutral, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:NOU.

Noumi Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
43
Neutral
AU$26.13M33.916.76%
41
Neutral
€30.48M-20.54%13.92%36.28%
41
Neutral
AU$20.23M5.77-29.43%102.21%69.47%
40
Underperform
AU$36.02M1.03%-52.56%
40
Underperform
€13.99M-184.71%39.53%49.99%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NOU
Noumi Limited
0.13
-0.15
-53.57%
AU:AHF
Australian Dairy Nutritionals Group
0.04
0.02
90.48%
AU:WNX
Wellnex Life Ltd
0.20
-0.36
-64.35%
AU:NUC
Nuchev Pty Ltd
0.13
-0.02
-13.33%
AU:HCT
Holista Colltech Limited
0.08
0.06
300.00%

Noumi Limited Corporate Events

Noumi Limited Reports Mixed Q4 FY25 Results Amid Legal and Market Challenges
Jul 31, 2025

Noumi Limited reported a slight decline in Q4 FY25 revenue to $155.2 million, with plant-based milks experiencing a 2.9% decrease, while dairy and nutritionals saw a 0.9% increase. Despite a negative operating cash flow of $2.2 million due to legal expenses, the company maintained a positive annual operating cash flow of $32.5 million. Noumi is optimistic about its FY25 earnings, expecting improved operating EBITDA, although it anticipates a net loss after tax due to depreciation, financing costs, and impairment charges. The company continues to see strong performance from its Milklab brand, particularly in retail and export channels, despite competitive pressures and macroeconomic challenges.

The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.

Noumi Limited Resolves Class Action, Paves Way for Future Growth
Jun 25, 2025

Noumi Limited has announced that the Victorian Supreme Court has approved the settlement terms of a class action lawsuit, marking the resolution of a significant legacy issue for the company. With the settlement, which includes Noumi’s $11.56 million contribution covered by insurance, the company can now focus on business growth and enhancing stakeholder value, as it moves past the financial restatements of FY19 and FY20.

The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 03, 2025